Hedge fund veteran issues major warning to investors about AI: ‘The bubble is ahead of us’
Following the surge of AI, the formation of a bubble and the impact on the economy when it bursts have been discussed a lot in the past couple of months. […]
Analog Devices: A $1000 Investment, 10 Years Later.
For many investors, the degree to which a stock’s price fluctuates is a key factor. Price movement not only affects your portfolio’s value, but it also allows you to benchmark […]
Buy 5 Financial Technology Ginats Amid Fed Rate Cut Hope in December
The Federal Reserve will hold its last FOMC (Federal Open Market Committee) meeting of 2025 on Dec. 9-10. Market participants are hopeful for a 25 basis-point cut in the benchmark […]
Ellison’s $349.5 Billion: The Double Dropout’s Secret
Financial success is often marketed in many forms, ranging from the absolutely dependable.investment* Strategizing for financial cutbacks and spending less than you earn. * Preparing for fiscal belt-tightening and keeping […]
15.9% Yield: Top 4 Mega Dividend Stocks
Investors lovedividend stocks and ETFs, notably those boasting exceptionally large yields, as they offer a significantpassive income stream and offer significant total returnTotal return encompasses interest, profits from selling assets, […]
3 ‘Strong Buy’ Technology Stocks Backed by Top Analysts, 10/03/25
The technology sector is in a state of continual transformation, driven by advancements in areas such as artificial intelligence (AI), cloud computing, semiconductors, cybersecurity, and more. Investors must allocate a portion of […]
After A 102% Rip Higher In 2025, Is Micron Technology Stock Delivering A New Buy Point Soon?
William O’Neil, the late founder and longtime chair of Investor’s Business Daily, often liked to say you buy on fundamentals and technicals, but then sell on technicals. Tuesday’s IBD 50 […]
REVB To Release Test Results This Quarter
By Brad Sorensen, CFA NASDAQ:REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and […]